Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 11, 2015 9:19:16 PM
I think it is positive that Musclepharm is defending it's sales in America....and that the decline in sales from last year's very strong Q1 sales can be explained almost entirely by a decline in international sales.
It makes perfect sense to me that Musclepharm focuses on America and a few International markets with strong currencies like UK and Australia right now.
Many purchasers from Brazil and elsewhere, probably delayed purchases for later, given the multi year lows of the Euro, the Brazilian real and the Canadian Dollar during Q1....so, more sales from there should be expected in Q2 after the 5-10% strengthening of these currencies versus the US dollar.
With Musclepharm's future endorsement and sponsorship contracts, it's natural to focus primarily on America though.
Musclepharm's goal should be to break even on US sales alone, and let international sales be the cream on the top...with $10-15 million contribution each quarter.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM